Treatment of hepatitis C virus in advanced renal disease
Rajani Sharma, Robert S. Brown – 29 September 2017
Early Biliary complications after liver transplantation
Kim Daniel, Adnan Said – 29 September 2017
Glutamine synthetase staining and CTTNB1 mutation in hepatocellular adenomas
Sanjay Kakar, Linda D. Ferrell – 29 September 2017
Innovative care models after liver transplant
C. Burcin Taner, Andrew P. Keaveny – 29 September 2017
Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus–coinfected patient with cure of hepatitis C by direct‐acting antiviral agents
Laetitia Mauge, Juliette Pavie, Dominique Batisse, Luc Darnige – 28 September 2017
Mitochondrial and anabolic pathways in hepatocellular carcinoma
Nikolai A. Timchenko – 28 September 2017
A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma
Ping Luo, Peiyuan Yin, Rui Hua, Yexiong Tan, Zaifang Li, Gaokun Qiu, Zhenyu Yin, Xingwang Xie, Xiaomei Wang, Wenbin Chen, Lina Zhou, Xiaolin Wang, Yanli Li, Hongsong Chen, Ling Gao, Xin Lu, Tangchun Wu, Hongyang Wang, Junqi Niu, Guowang Xu – 28 September 2017 – Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide. The lack of effective biomarkers for the early detection of HCC results in unsatisfactory curative treatments. Here, metabolite biomarkers were identified and validated for HCC diagnosis.
Liver immunology: A new section for the journal
Ginny L. Bumgardner – 28 September 2017
Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus–coinfected patient with cure of hepatitis C by direct‐acting antiviral agents
Laetitia Mauge, Juliette Pavie, Dominique Batisse, Luc Darnige – 28 September 2017
Distinct role of nuclear receptor corepressor 1 regulated de novo fatty acids synthesis in liver regeneration and hepatocarcinogenesis in mice
Qing Ou‐Yang, Xi‐Meng Lin, Yan‐Jing Zhu, Bo Zheng, Liang Li, Ying‐Cheng Yang, Guo‐Jun Hou, Xin Chen, Gui‐Juan Luo, Feng Huo, Qi‐Bin Leng, Frank J. Gonzalez, Xiao‐Qing Jiang, Hong‐Yang Wang, Lei Chen – 28 September 2017 – It is urgent that the means to improve liver regeneration (LR) be found, while mitigating the concurrent risk of hepatocarcinogenesis (HCG). Nuclear receptor corepressor 1 (NCoR1) is a co‐repressor of nuclear receptors, which regulates the expression level of metabolic genes; however, little is known about its potential contribution for LR and HCG.